MyFinsight
Home
Blog
About
GRI Bio, Inc. (GRI)
GRI Bio, Inc. (GRI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$101K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Accounts payable
Accrued expenses
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Payment of stock issuance costs
Operating lease liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,643
-1,998
-2,659
-3,359
Depreciation expense
0
1
1
1
Stock-based compensation expense
33
31
67
465
Change in fair value of warrant liability
-
-
0
0
Change in operating lease right-of-use assets
14
13
12
13
Prepaid expenses and other current assets
156
-105
14
-132
Accounts payable
223
-1,507
272
20
Accrued expenses
97
-317
-638
428
Operating lease liabilities
-14
-13
-12
-13
Cash used in operating activities
-1,446
-3,685
-2,971
-2,313
Purchase of property and equipment
-
-
3
-
Cash used in investing activities
-
-
-3
-
Proceeds from issuance of common stock in financing transaction / under atm facility-Through Financing
-
-
8,000
0
Proceeds from issuance of common stock under atm facility-Financing Transactions
0
-
-
-
Proceeds from issuance of common stock under atm facility-At The Market Offering
8,214
-
0
1,619
Proceeds from warrant exercise
-
-
0
0
Proceeds from issuance of common stock under atm facility
-
6,819
-
-
Payment for fractional shares in connection with reverse stock split
0
1
0
0
Payment of stock issuance costs
50
314
852
373
Cash provided by financing activities
1,345
6,504
7,148
1,246
Net increase in cash and cash equivalents
-101
2,819
4,174
-1,067
Cash and cash equivalents at beginning of period
11,048
8,229
4,055
5,028
Cash and cash equivalents at end of period
10,947
11,048
8,229
4,055
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock under atm...
$8,214K
(772.90%↑ Y/Y)
Cash provided by
financing activities
$1,345K
(-73.08%↓ Y/Y)
Canceled cashflow
$6,869K
Net increase in cash
and cash...
-$101K
(-207.45%↓ Y/Y)
Canceled cashflow
$1,345K
Accounts payable
$223K
(-39.89%↓ Y/Y)
Accrued expenses
$97K
(-63.94%↓ Y/Y)
Stock-based compensation
expense
$33K
(-87.36%↓ Y/Y)
Change in operating
lease right-of-use...
$14K
(-39.13%↓ Y/Y)
something is missing
-$6,819K
Payment of stock
issuance costs
$50K
(-94.70%↓ Y/Y)
Cash used in
operating activities
-$1,446K
(70.50%↑ Y/Y)
Canceled cashflow
$367K
Net loss
-$1,643K
(72.33%↑ Y/Y)
Prepaid expenses and
other current assets
$156K
(217.29%↑ Y/Y)
Operating lease
liabilities
-$14K
(39.13%↑ Y/Y)
Buy us a coffee